Isoprostanes, a new group of substances in angiology - Of value in the future?

被引:0
|
作者
Aghajanian, AA
Oguogho, A
Sinzinger, H
机构
[1] WILHELM AUERSWALD ATHEROSKLEROSEFORSCHUNGSGRP,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,KLIN NUKL MED,A-1090 VIENNA,AUSTRIA
来源
VASA-JOURNAL OF VASCULAR DISEASES | 1997年 / 26卷 / 02期
关键词
atherosclerosis; oxidative stress; prostaglandin; isoprostane;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
F-2-isoprostanes are prostaglandin F-2-like compounds being formed bq non-enzymatic peroxidation of arachidonic acid in vivo. They have a variety of biological actions. The most important compound of this group is 8-epi-PGF(2 alpha) being capable to induce vasoconstriction in particular of lung- and renal vascular tissue. Isoprostanes are present in esterified form; in free form they become available after hydrolysis by phospholipase A. An increase in isoprostanes is an important indicator of oxidative stress in-vivo due to a variety of different noxi such as metal- or nonmetal ions or cigarette smoke. Isoprostanes show an activation of platelets; as a consequence of the interaction of 8-epi-PGF(2 alpha) with specific receptors platelet aggregation may be induced or may be enhanced together with other agonists. Due to these preliminary results isoprostanes could become an interesting substance in angiology in the future for diagnosis of oxidative stress as well as in the understanding of the pathogenesis of atherosclerosis.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [1] The isoprostanes - Current knowledge and directions for future research
    Morrow, JD
    Roberts, LJ
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (01) : 1 - 9
  • [2] Plasma Isoprostanes, but Not Thiobarbituic Acid Reactive Substances, Are a Reliable Measure of Lipid Oxidation in Growing Pigs Fed Peroxidized
    Wilson, Victoria C.
    Kerr, Brian J.
    JOURNAL OF ANIMAL SCIENCE, 2021, 99 : 65 - 66
  • [3] Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances
    Mas, Emilie
    Barden, Anne
    Durand, Thierry
    Galano, Jean-Marie
    Croft, Kevin D.
    Mori, Trevor A.
    FREE RADICAL RESEARCH, 2010, 44 (02) : 191 - 198
  • [4] Isoprostanes: new markers of oxidative stress. Fundamental and clinical data
    Cracowski, JL
    Stanke-Labesque, F
    Bessard, G
    REVUE DE MEDECINE INTERNE, 2000, 21 (03): : 304 - 307
  • [5] Possibilities to group nanomaterials across different substances - A case study on organic pigments
    Jeliazkova, Nina
    Ma-Hock, Lan
    Janer, Gemma
    Stratmann, Heidi
    Wohlleben, Wendel
    NANOIMPACT, 2022, 26
  • [6] New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
    Chatzianagnostou, Kyriazoula
    Gaggini, Melania
    Suman Florentin, Adrian
    Simonini, Ludovica
    Vassalle, Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [7] Multi-sample analytical workflow for the determination of isoprostanes in oral fluid: A new tool for non-invasive evaluation of oxidative stress
    Bartolini, Francesco
    Croce, Martina
    Della Valle, Francesco
    Montesano, Camilla
    Fanti, Federico
    Compagnone, Dario
    Sergi, Manuel
    TALANTA, 2025, 285
  • [8] New Mutant Amaranth Varieties as a Potential Source of Biologically Active Substances
    Fejer, Jozef
    Kron, Ivan
    Eliasova, Adriana
    Grulova, Daniela
    Gajdosova, Alena
    Lancikova, Veronika
    Hricova, Andrea
    ANTIOXIDANTS, 2021, 10 (11)
  • [9] A new approach to the synthesis of polyunsaturated deuterated isoprostanes: Total synthesis of d4-5-epi-8,12-iso-iPF3α-VI and d4-8,12-iso-iPF3α-VI
    Chang, Chih-Tsung
    Patel, Pranav
    Gore, Vivek
    Song, Wen-Liang
    Lawson, John A.
    Powell, William S.
    FitzGerald, Garret A.
    Rokach, Joshua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6755 - 6758
  • [10] New techniques to detect oxidative stress markers: Mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo
    Yin, Huiyong
    BIOFACTORS, 2008, 34 (02) : 109 - 124